Company Tetralogic Pharmaceuticals Corp Nasdaq
Equities
US88165U1097
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
President | - | - | |
Treasurer | 66 | 14-01-31 | |
Dick L. Sherman
SEC | Corporate Secretary | 76 | 12-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 24,769,083 | 24,769,083 ( 100.00 %) | 0 | 100.00 % |
Company contact information
TetraLogic Pharmaceuticals Corp.
343 Phoenixville Pike
19355-9603, Malvern
+610 889 9900
Sector
1st Jan change | Capi. | |
---|---|---|
-3.46% | 102B | |
+1.41% | 96.29B | |
+2.13% | 22.18B | |
-15.84% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.65% | 16.36B | |
+4.39% | 13.97B | |
+31.35% | 12.17B |